Anti-tumor necrosis factor (anti-TNF) biologics are established and effective treatments for a number of chronic inflammatory diseases including rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), psoriasis (PSO), and Crohn’s disease (CD). This evidence concerns the gene TNF and psoriasis.